Difference between revisions of "GENialOMICS"
From LMU BioDB 2015
(added work status table -- needs to reformatted to have names across columns and goals/progress down rows) |
(→Week 10: removed week 11 information) |
||
Line 6: | Line 6: | ||
*On November 3, 2015, GÉNialOMICS chose to create database for ''Burkholderia cenocepacia''. | *On November 3, 2015, GÉNialOMICS chose to create database for ''Burkholderia cenocepacia''. | ||
*On November 5, 2015, a journal detailing the complete genome of ''Burkholderia cenocepacia'' (strain J2315) titled [http://jb.asm.org/content/191/1/261.short The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients] was found. | *On November 5, 2015, a journal detailing the complete genome of ''Burkholderia cenocepacia'' (strain J2315) titled [http://jb.asm.org/content/191/1/261.short The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients] was found. | ||
− | |||
<br> | <br> | ||
Revision as of 23:54, 12 November 2015
Weekly Group Assignments | Shared Group Journals | Project Links | Team Members |
---|---|---|---|
|
|
|
|
Week 10
- On November 3, 2015, GÉNialOMICS chose to create database for Burkholderia cenocepacia.
- On November 5, 2015, a journal detailing the complete genome of Burkholderia cenocepacia (strain J2315) titled The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients was found.
Weel 11
Weekly Goals and Progress | ||||||||
---|---|---|---|---|---|---|---|---|
Anu Varshneya | Goals |
| ||||||
Progress |
| |||||||
Brandon Litvak | Goals | |||||||
Progress |
| |||||||
Veronica Pacheco | Goals |
Work with Kevin Wyllie
| ||||||
Progress | ||||||||
Kevin Wyllie | Goals |
Work with Veronica Pacheco
| ||||||
Progress |
Other Progress:
- A journal using the B. cenocepacia genome in a microarray experiment titled Biofilm-Grown Burkholderia cepacia Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species was approved for analysis.